Search results for gsk

GSK announced significant new price reductions for its HIV medicines offered on a not-for-profit basis to the world's poorest countries. This reduction is the fifth time the company has made a price read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline reported its 2007 global giving to charitable initiatives totalled £282 million, equivalent to almost 4% of pre-tax profits for the company (with the FTSE 100 average around 1%). Dona read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline said this morning that a vaccine that could help prevent an outbreak of the H5N1 'bird flu' virus had been approved by the European Commission. The vaccine, Prepandrix, is the first read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline (GSK) is launching a ground-breaking new concept which will tap into the highest quality thinking in academia to optimise the early clinical development of new GSK medicines in a mode read more »
Discuss   Add this link to...  Bury
The draft recommendations announced yesterday by NICE in the second technology appraisal consultation document (ACD) suggest that Tyverb (lapatinib) should not be used in the NHS, except in clinical read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline plc (GSK) has announced that it will acquire the Egyptian mature products business of Bristol Myers Squibb (BMS), for $210 (£125) million, in a move to accelerate sales growth and fur read more »
Discuss   Add this link to...  Bury
InforSense Ltd., the leading provider of next generation business and scientific intelligence tools, has successfully completed a pilot project at world leading pharmaceutical company GlaxoSmithKline read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline [LSE/NYSE: GSK] and Genelabs Technologies, Inc. [NASDAQ: GNLB] have entered into a definitive agreement pursuant to which GSK will acquire Genelabs for approximately $57 million (£35 read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline (GSK) has signed an exclusive Cooperation Agreement with Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (NIBT) as a preliminary step in forming a Joint Venture (JV) between the tw read more »
Discuss   Add this link to...  Bury
GlaxoSmithKline has announced a new global policy to voluntarily stop all corporate political contributions. In the past, GSK - in common with many companies and in full compliance with local laws - read more »
Discuss   Add this link to...  Bury